These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 14033374)

  • 21. Bacterial pathogens and outcome determinants of childhood pyogenic meningitis in Ilorin, Nigeria.
    Johnson WB; Adedoyin OT; Abdulkarim AA; Olanrewaju WI
    Afr J Med Med Sci; 2001 Dec; 30(4):295-303. PubMed ID: 14510107
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A selective medium with lincomycin and colistin used in isolation of N. gonorrhoeae and N. meningitidis.
    Potuznik V
    J Hyg Epidemiol Microbiol Immunol; 1969; 13(3):366-73. PubMed ID: 4980820
    [No Abstract]   [Full Text] [Related]  

  • 23. THE DEMONSTRATION OF N. GONORRHOEAE WITH THE AID OF FLUORESCENT ANTIBODIES. 1. IMMUNOLOGICAL STUDIES OF ANTIGONOCOCCAL SERA AND THEIR FLUORESCEIN-LABELLED GLOBULINS, WITH PARTICULAR REGARD TO SPECIFICITY.
    DANIELSSON D
    Acta Derm Venereol; 1963; 43():451-64. PubMed ID: 14061556
    [No Abstract]   [Full Text] [Related]  

  • 24. DANOMYCIN, A NEW ANTIBIOTIC.
    TSUKIURA H; OKANISHI M; OHMORI T; KOSHIYAMA H; MIYAKI T; KITAZIMA H; KAWAGUCHI H
    J Antibiot (Tokyo); 1964 Mar; 17():39-47. PubMed ID: 14157008
    [No Abstract]   [Full Text] [Related]  

  • 25. Simultaneous single-tube PCR assay for the detection of Neisseria meningitidis, Haemophilus influenzae type b and Streptococcus pneumoniae.
    Tzanakaki G; Tsopanomichalou M; Kesanopoulos K; Matzourani R; Sioumala M; Tabaki A; Kremastinou J
    Clin Microbiol Infect; 2005 May; 11(5):386-90. PubMed ID: 15819865
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Activity of gemifloxacin against Streptococcus pneumoniae and Haemophilus influenzae.
    Morrissey I; Tillotson G
    J Antimicrob Chemother; 2004 Feb; 53(2):144-8. PubMed ID: 14729748
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Nalidixic acid. Therapeutic trial and antimicrobial activity in vitro. Preliminary study].
    TOVIA ARRIOJA F; RAMIREZ VILLALPANDO A
    Prensa Med Mex; 1963 Jan; 28():47-53. PubMed ID: 13993872
    [No Abstract]   [Full Text] [Related]  

  • 28. Bacterial profile and clinical outcome of childhood meningitis in rural Yemen: a 2-year hospital-based study.
    Al Khorasani A; Banajeh S
    J Infect; 2006 Oct; 53(4):228-34. PubMed ID: 16434101
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bacterial genome sizes determined by DNA renaturation studies.
    Bak AL; Christiansen C; Stenderup A
    J Gen Microbiol; 1970 Dec; 64(3):377-80. PubMed ID: 4396963
    [No Abstract]   [Full Text] [Related]  

  • 30. Children with bacterial meningitis presenting to the emergency department during the pneumococcal conjugate vaccine era.
    Nigrovic LE; Kuppermann N; Malley R;
    Acad Emerg Med; 2008 Jun; 15(6):522-8. PubMed ID: 18616437
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antimicrobial activity of the new macrolide flurithromycin against Haemophilus influenzae, Streptococcus pneumoniae, Streptococcus pyogenes, Branhamella catarrhalis and Staphylococcus aureus.
    Nord CE; Lindmark A; Persson I
    J Chemother; 1989 Jul; 1(4 Suppl):203-4. PubMed ID: 16312369
    [No Abstract]   [Full Text] [Related]  

  • 32. Aetiology of bacterial meningitis and resistance to antibiotics of causative pathogens in Europe and in the Mediterranean region.
    Tzanakaki G; Mastrantonio P
    Int J Antimicrob Agents; 2007 Jun; 29(6):621-9. PubMed ID: 17368858
    [TBL] [Abstract][Full Text] [Related]  

  • 33. RAPID METHOD FOR DEMONSTRATING BILE SOLUBILITY OF DIPLOCOCCUS PNEUMONIAE.
    HAWN CV; BEEBE E
    J Bacteriol; 1965 Aug; 90(2):549. PubMed ID: 14329473
    [No Abstract]   [Full Text] [Related]  

  • 34. Optimising the use of conjugate vaccines to prevent disease caused by Haemophilus influenzae type b, Neisseria meningitidis and Streptococcus pneumoniae.
    Trotter CL; McVernon J; Ramsay ME; Whitney CG; Mulholland EK; Goldblatt D; Hombach J; Kieny MP;
    Vaccine; 2008 Aug; 26(35):4434-45. PubMed ID: 18617296
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antimicrobial activity of tigecycline against recent isolates of respiratory pathogens from Asian countries.
    Ko KS; Song JH; Lee MY; Park S; Kwon KT; Heo ST; Ryu SY; Oh WS; Peck KR; Lee NY
    Diagn Microbiol Infect Dis; 2006 Aug; 55(4):337-41. PubMed ID: 16631337
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [In vitro resistance rates of Streptococcus pneumoniae and Haemophilus influenzae clinical isolates to the antibiotics used in therapy].
    Uncu H; Colakoğlu S; Turunç T; Demiroğlu YZ; Arslan H
    Mikrobiyol Bul; 2007 Jul; 41(3):441-6. PubMed ID: 17933256
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immune responses to polysaccharides: lessons from humans and mice.
    González-Fernández A; Faro J; Fernández C
    Vaccine; 2008 Jan; 26(3):292-300. PubMed ID: 18160186
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Moxifloxacin and ciprofloxacin protect human respiratory epithelial cells against Streptococcus pneumoniae, Staphylococcus aureus, Pseudomonas aeruginosa, and Haemophilus influenzae in vitro.
    Ulrich M; Berger J; Möller JG; Döring G
    Infection; 2005 Dec; 33 Suppl 2():50-4. PubMed ID: 16518712
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [STUDIES ON A NEW ANTITUMOR ANTIBIOTIC, TA-435 A. I. STUDIES ON ITS ISOLATION, PROPERTIES AND BIOLOGICAL ACTIVITY].
    NAGAHAMA N; FURUMAI T; ARAI Y; ASHIKARI Y
    J Antibiot B; 1964 Dec; 17():245-9. PubMed ID: 14266498
    [No Abstract]   [Full Text] [Related]  

  • 40. Antibodies in saliva.
    KRAUS FW; KONNO J
    Ann N Y Acad Sci; 1963 Mar; 106():311-29. PubMed ID: 14035549
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.